Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes
Abstract Background Mutations in the KEAP1-NFE2L2 signaling pathway were linked to increased tumorigenesis and aggressiveness. Interestingly, not all hotspot mutations on NFE2L2 were damaging; some even were activating. However, there was conflicting evidence about the association between NFE2L2 mut...
Những tác giả chính: | Kewei Wang, Zixi Li, Ying Xuan, Yong Zhao, Chao Deng, Meidan Wang, Chenjun Xie, Fenglai Yuan, Qingfeng Pang, Wenjun Mao, Dongyan Cai, Zhangfeng Zhong, Jie Mei |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
BMC
2023-10-01
|
Loạt: | Cancer Cell International |
Những chủ đề: | |
Truy cập trực tuyến: | https://doi.org/10.1186/s12935-023-03056-9 |
Những quyển sách tương tự
-
Metformin suppresses NFE2L1 pathway activation to inhibit gap junction beta protein expression in NSCLC
Bằng: Shuo Yu, et al.
Được phát hành: (2024-04-01) -
Multi-Omics Analysis of Molecular Characteristics and Carcinogenic Effect of NFE2L3 in Pan-Cancer
Bằng: Mengxiao Liu, et al.
Được phát hành: (2022-06-01) -
NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases
Bằng: Kamila Łuczyńska, et al.
Được phát hành: (2024-02-01) -
Cisplatin Disrupts Proteasome Bounce-Back Effect through Suppressing ZEB1/Nfe2l1 in Cholangiocarcinoma
Bằng: Yuancai Xiang, et al.
Được phát hành: (2024-03-01) -
Understanding the Transcription Factor NFE2L1/NRF1 from the Perspective of Hallmarks of Cancer
Bằng: Haomeng Zhang, et al.
Được phát hành: (2024-06-01)